CN106632302A - Synthesis method of 1-(thiazole-2-yl)piperidine-4-ol - Google Patents

Synthesis method of 1-(thiazole-2-yl)piperidine-4-ol Download PDF

Info

Publication number
CN106632302A
CN106632302A CN201611159395.5A CN201611159395A CN106632302A CN 106632302 A CN106632302 A CN 106632302A CN 201611159395 A CN201611159395 A CN 201611159395A CN 106632302 A CN106632302 A CN 106632302A
Authority
CN
China
Prior art keywords
piperidines
thiazol
synthetic method
alcohol
alcohol according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201611159395.5A
Other languages
Chinese (zh)
Inventor
茅仲平
马东旭
葛永辉
任雪景
黄从报
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SUZHOU HANDE CHUANGHONG BIOCHEMICAL TECHNOLOGY Co Ltd
Original Assignee
SUZHOU HANDE CHUANGHONG BIOCHEMICAL TECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SUZHOU HANDE CHUANGHONG BIOCHEMICAL TECHNOLOGY Co Ltd filed Critical SUZHOU HANDE CHUANGHONG BIOCHEMICAL TECHNOLOGY Co Ltd
Priority to CN201611159395.5A priority Critical patent/CN106632302A/en
Publication of CN106632302A publication Critical patent/CN106632302A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Abstract

The invention discloses a synthesis method of 1-(thiazole-2-yl)piperidine-4-ol. The synthesis method comprises the following steps: adding an alkali A into a reaction container filled with 4-hydroxypiperidine, 2-bromothiazole and a solvent and stirring and reacting at 50 DEG C-120 DEG C for 6-16 hours to obtain a crude product; and carrying out post-treatment on the crude product to obtain the 1-(thiazole-2-yl)piperidine-4-ol. According to the method disclosed by the invention, a product does not need to be purified by column chromatography; a synthesis route is short; and the product purity is high and the yield is high.

Description

The synthetic method of 1- (thiazol-2-yl) piperidines -4- alcohol
Technical field
The invention belongs to the synthesis field of organic compound, and in particular to a kind of conjunction of 1- (thiazol-2-yl) piperidines -4- alcohol Into method.
Background technology
1- (thiazol-2-yl) piperidines -4- alcohol is a kind of important organic intermediate, its extensive drug application chemical field. First, in the medicine treated or adjust diabetes, g protein coupled receptor 40 (GPR40) is a kind of potential treatment diabetes Drug target, and GPR40 be also believed to it is relevant with some mental disorders and cancer.Therefore, 1- (thiazol-2-yl) piperazine Pyridine -4- alcohol molecule has important using value as the important skeleton of GPR40 in above-mentioned field of medicaments.Secondly, stearoyl-coa Dehydrogenase (SCD) is to participate in the key enzyme that metabolism is adjusted, in having been applied to many relevant metabolic diseases, bag Include the metabolic syndrome disease such as type ii diabetes, obesity.And changing comprising 1- (thiazol-2-yl) piperidines -4- alcohol fragments in molecule Entering type SCD can effectively improve its pharmacokinetics, therefore 1- (thiazol-2-yl) piperidines -4- alcohol and its derivative in treatment generation There is important using value in the medicine for thanking to Syndrome disease.
The synthesis of 1- (thiazol-2-yl) piperidines -4- alcohol is rarely reported at present.Known method 1) produced using column chromatography purifying Thing, operation inconvenience, produces the solid wastes such as substantial amounts of silica gel, is difficult industrialized production;2) yield is low, and yield is generally 24%- 50%).
The content of the invention
The technical problem to be solved in the present invention is the defect for overcoming prior art, there is provided a kind of 1- (thiazol-2-yl) piperidines- The synthetic method of 4- alcohol, without the need for column chromatography purified product, product purity is high, and yield is high for the method.
To solve above-mentioned technical problem, the technical solution used in the present invention is:
A kind of synthetic method of 1- (thiazol-2-yl) piperidines -4- alcohol, comprises the following steps:To equipped with 4- hydroxy piperidines, 2- In the reaction vessel of bromo thiazole and solvent, add alkali A, the stirring reaction 6-16 hour at 50-120 DEG C to obtain crude product, then will Crude product is post-processed, and obtains 1- (thiazol-2-yl) piperidines -4- alcohol.
Raw materials used and related reagent can be commercially available by commercial means in the present invention.The wherein knot of 4- hydroxy piperidines Structure formula is:The structural formula of 2- bromo thiazoles isAlleged by the present invention the step of " post processing " in Column chromatography purification step is not included.
Preferably, the post-processing step of the crude product includes adjusting PH:It is 5-7 first to adjust PH with acid, then molten with alkali B again It is 10-12 that liquid adjusts PH.
Preferably, post processing is additionally included in the washing adjusted before PH, and the extraction after PH is adjusted, drying and mistake Filter.
Preferably, the acid is watery hydrochloric acid, and the alkali B solution is unsaturated carbonate potassium solution or saturated sodium carbonate solution.
Preferably, the watery hydrochloric acid concentration is 2M/L.
Preferably, the solvent is selected from toluene, acetonitrile, DMF, DMA Plant or several.
Preferably, the alkali A selected from the -5- alkene of 1,5- diazabicylos [5.4.0] 11, pyridine, sodium carbonate, potassium carbonate, One or more in cesium carbonate, caustic alcohol.
Preferably, the 4- hydroxy piperidines and the mol ratio of 2- bromo thiazoles are 1.2~2.0:1.
Preferably, the 2- bromo thiazoles and the mol ratio of alkali A are 1:1.5~3.0.
The beneficial effect that the present invention is reached:
The low in raw material price that the method is used, is readily available, and only needs to single step reaction, easy to operate, yield and Chemical purity is high, it is easy to industrialized production.And reaction is not required to special producing equipment, without (pole) low-temperature operation, it is to avoid existing side The operations such as low, the purifying trouble of yield of method, have a good application prospect.
Description of the drawings
Fig. 1 is the synthetic route chart of 1- (thiazol-2-yl) piperidines -4- alcohol.
Specific embodiment
Below in conjunction with the accompanying drawings the invention will be further described.Following examples are only used for clearly illustrating the present invention Technical scheme, and can not be limited the scope of the invention with this.
Embodiment 1
81 grams of 2- bromo thiazoles, 123 grams of sodium carbonate and 81 milliliters of N, N- dimethyl are added in the reaction bulb with agitator Formamide, 60 grams of 4- hydroxy piperidines are added under room temperature in gained mixture, control interior temperature 70-80 DEG C, react 10 hours.So Afterwards reactant mixture is added into 400 milliliters of ethyl acetate and 200 milliliters of saturated aqueous common salts, separate organic phase, continued with 200 milliliters Twice, gained organic phase is adjusted to pH=6 to saturated common salt washing organic phase with 2M/L aqueous hydrochloric acid solutions, separates organic phase, organic phase Washed once with 2M/L aqueous hydrochloric acid solutions again.Then gained water is adjusted to pH=12 under ice bath with unsaturated carbonate aqueous solutions of potassium, plus Enter dichloromethane extraction, sodium sulphate is dried, and filters, and filter cake is washed with a small amount of dichloromethane, concentration is dry after organic phase merges, and obtains 69 grams of light yellow oil 1- (thiazol-2-yl) piperidines -4- alcohol, yield 76%.
1H NMR(400MHz,CDCl3):7.46(d,1H),6.58(d,1H),3.99(m,1H),3.87(m,2H),3.28 (m, 2H), 1.99 (m, 2H), 1.68 (m, 2H).
Embodiment 2
81 grams of 2- bromo thiazoles, 123 grams of cesium carbonates and 81 milliliters of acetonitriles are added in the reaction bulb with agitator, under room temperature 60 grams of 4- hydroxy piperidines are added in gained mixture, interior temperature 80-90 DEG C is controlled, 7 hours are reacted.Then by reactant mixture Filter, filter cake is washed with a small amount of ethyl acetate, after organic phase concentration 400 milliliters of ethyl acetate, resulting solution 2M/L salt are added Aqueous acid is adjusted to pH=6, separates organic phase, and organic phase is washed again once with 2M/L aqueous hydrochloric acid solutions.Then gained water is in ice PH=12 is adjusted to unsaturated carbonate aqueous solutions of potassium under bath, adds dichloromethane extraction, sodium sulphate to be dried, filtered, filter cake is used a small amount of Dichloromethane is washed, and concentration is dry after organic phase merges, and obtains 73.7 grams of light yellow oil 1- (thiazol-2-yl) piperidines -4- alcohol, Yield 81%.
Embodiment 3
8100 grams of 2- bromo thiazoles, 12300 grams of sodium carbonate and 10 liters of N, N- diformazans are added in the reaction bulb with agitator Base formamide, 6000 grams of 4- hydroxy piperidines are added under room temperature in gained mixture, control interior temperature 50-60 DEG C, and reaction 15 is little When.Then reactant mixture is added into 40 liters of ethyl acetate and 20 liters of saturated aqueous common salts, separates organic phase, continued with 20 liters of saturations Twice, gained organic phase is adjusted to pH=6 to salt washing organic phase with 2M/L aqueous hydrochloric acid solutions, separates organic phase, and organic phase is used again 2M/L aqueous hydrochloric acid solutions are washed once.Then gained water is adjusted to pH=12 under ice bath with unsaturated carbonate aqueous solutions of potassium, adds two Chloromethanes is extracted, and sodium sulphate is dried, and is filtered, and filter cake is washed with a small amount of dichloromethane, and concentration is dry after organic phase merges, and obtains 7370 Gram light yellow oil 1- (thiazol-2-yl) piperidines -4- alcohol, yield 81%, purity is more than 99%.
Embodiment 4
16.2 kilograms of 2- bromo thiazoles, 25 kilograms of sodium carbonate and 21 liters of acetonitriles, room are added in the reaction bulb with agitator 12.3 kilograms of 4- hydroxy piperidines are added in gained mixture under temperature, interior temperature 110-120 DEG C is controlled, 6 hours are reacted.Then will Reactant mixture is filtered, and filter cake is washed with a small amount of ethyl acetate, adds 70 liters of ethyl acetate, resulting solution to use after organic phase concentration 2M/L aqueous hydrochloric acid solutions are adjusted to pH=6, separate organic phase, and organic phase is washed again once with 2M/L aqueous hydrochloric acid solutions.Then water obtained by PH=12 is adjusted to unsaturated carbonate aqueous solutions of potassium under ice bath, adds dichloromethane extraction, sodium sulphate to be dried, filtered, filter cake Washed with a small amount of dichloromethane, concentration is dry after organic phase merges, and obtains 15.11 kilograms of light yellow oils 1- (thiazol-2-yl) Piperidines -4- alcohol, yield 83%, purity is more than 99%.
The above is only the preferred embodiment of the present invention, it is noted that for the ordinary skill people of the art For member, on the premise of without departing from the technology of the present invention principle, some improvement and deformation can also be made, these improve and deform Also should be regarded as protection scope of the present invention.

Claims (9)

1. a kind of synthetic method of 1- (thiazol-2-yl) piperidines -4- alcohol, it is characterised in that comprise the following steps:To equipped with 4- hydroxyls In the reaction vessel of phenylpiperidines, 2- bromo thiazoles and solvent, alkali A is added, stirring reaction 6-16 hour, obtains slightly at 50-120 DEG C Product, then post-process crude product, obtain 1- (thiazol-2-yl) piperidines -4- alcohol.
2. the synthetic method of 1- (thiazol-2-yl) piperidines -4- alcohol according to claim 1, it is characterised in that the crude product Post-processing step include adjust PH:It is 5-7 first to adjust PH with acid, and it is 10-12 then to adjust PH with alkali B solution again.
3. the synthetic method of 1- (thiazol-2-yl) piperidines -4- alcohol according to claim 2, it is characterised in that post processing is also The washing being included in before regulation PH, and extraction, drying and the filtration after PH is adjusted.
4. the synthetic method of 1- (thiazol-2-yl) piperidines -4- alcohol according to claim 2, it is characterised in that the acid is Watery hydrochloric acid, the alkali B solution is unsaturated carbonate potassium solution or saturated sodium carbonate solution.
5. the synthetic method of 1- (thiazol-2-yl) piperidines -4- alcohol according to claim 4, it is characterised in that dilute salt Acid concentration is 2M/L.
6. the synthetic method of 1- (thiazol-2-yl) piperidines -4- alcohol according to any one of claim 1-5, it is characterised in that One or more of the solvent in toluene, acetonitrile, N,N-dimethylformamide, DMAC N,N' dimethyl acetamide.
7. the synthetic method of 1- (thiazol-2-yl) piperidines -4- alcohol according to any one of claim 1-5, it is characterised in that The alkali A is in -5- the alkene of 1,5- diazabicylos [5.4.0] 11, pyridine, sodium carbonate, potassium carbonate, cesium carbonate, caustic alcohol One or more.
8. the synthetic method of 1- (thiazol-2-yl) piperidines -4- alcohol according to any one of claim 1-5, it is characterised in that The 4- hydroxy piperidines are 1.2~2.0 with the mol ratio of 2- bromo thiazoles:1.
9. the synthetic method of 1- (thiazol-2-yl) piperidines -4- alcohol according to any one of claim 1-5, it is characterised in that The 2- bromo thiazoles are 1 with the mol ratio of alkali A:1.5~3.0.
CN201611159395.5A 2016-12-15 2016-12-15 Synthesis method of 1-(thiazole-2-yl)piperidine-4-ol Pending CN106632302A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201611159395.5A CN106632302A (en) 2016-12-15 2016-12-15 Synthesis method of 1-(thiazole-2-yl)piperidine-4-ol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201611159395.5A CN106632302A (en) 2016-12-15 2016-12-15 Synthesis method of 1-(thiazole-2-yl)piperidine-4-ol

Publications (1)

Publication Number Publication Date
CN106632302A true CN106632302A (en) 2017-05-10

Family

ID=58823630

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201611159395.5A Pending CN106632302A (en) 2016-12-15 2016-12-15 Synthesis method of 1-(thiazole-2-yl)piperidine-4-ol

Country Status (1)

Country Link
CN (1) CN106632302A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201309639A (en) * 2011-02-17 2013-03-01 Lg Life Sciences Ltd Oxime derivatives as GPR119 agonists
CN104918935A (en) * 2012-11-16 2015-09-16 百时美施贵宝公司 Dihydropyrazole gpr40 modulators
WO2016107832A1 (en) * 2014-12-30 2016-07-07 F. Hoffmann-La Roche Ag Novel tetrahydropyridopyrimidines and tetrahydropyridopyridines for the treatment and prophylaxis of hepatitis b virus infection

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201309639A (en) * 2011-02-17 2013-03-01 Lg Life Sciences Ltd Oxime derivatives as GPR119 agonists
CN104918935A (en) * 2012-11-16 2015-09-16 百时美施贵宝公司 Dihydropyrazole gpr40 modulators
WO2016107832A1 (en) * 2014-12-30 2016-07-07 F. Hoffmann-La Roche Ag Novel tetrahydropyridopyrimidines and tetrahydropyridopyridines for the treatment and prophylaxis of hepatitis b virus infection

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
安德森著,胡文浩等译: "《实用有机合成工艺研发手册》", 31 January 2011, 科学出版社 *
施韦特利克等编著,万均等译: "《有机合成实验手册》", 30 June 2010, 化学工业出版社 *

Similar Documents

Publication Publication Date Title
CN103524440B (en) The preparation method of gout therapertics Lesinurad and Lesinurad intermediate
CN107365275A (en) The Sai Lexipa of high-purity
CN101962379B (en) Method for refining sulfonyl isoquinoline derivative
CN102395591B (en) Method for preparing prasugrel
CN107365297A (en) A kind of Preparation Method And Their Intermediate of the benzyl propionate derivant of 2 methyl 2 '
CN103864802A (en) Preparation method of high-purity asenapine maleate
CN106554354B (en) The preparation method of the intermediate of Li Gelieting or its analog and Li Gelieting or its analog
CN106883192B (en) The synthetic method of the benzoic acid derivative of nitrogenous class heterocyclic antineoplastic pharmaceutical actives oxazolyl modification
CN103896858B (en) The preparation technology of cytosine
CN106565531A (en) Synthesis method for pharmaceutically acceptable salt of alkylhydrazine
CN106632302A (en) Synthesis method of 1-(thiazole-2-yl)piperidine-4-ol
CN106749098B (en) A kind of preparation method preparing dioxopromethazine hydrochloride using oxygen as oxidant
CN103896859B (en) The technique of synthesizing cytimidine
CN105037193A (en) Preparation method of otilonium bromide
CN105732547A (en) Preparation method of dehydrated andrographolide diacid half ester basic salt
CN104628718A (en) Method for synthesizing scopolamine and salts thereof
CN105732375B (en) A kind of method that gallic acid synthesizes 3,4,5-tri-methoxybenzoate
CN103819399A (en) Method for producing high-purity mannityl nicotinate
CN104447528B (en) The preparation method of pyridine-2,3-diethyl dicarboxylate
CN113582920B (en) Synthetic method of 4- (4-pyridyl) morpholine
CN107011254A (en) A kind of synthesis of picoline of 2 amino 4 and its purification process
CN112430205B (en) Preparation method of arylpyrrole compound
CN107235872A (en) A kind of preparation method of the red sugar alcohol of two sulphur
CN103288646B (en) Preparation method of fenofibrate nitrate
CN105732374B (en) A kind of method of 3,4,5-tri-methoxybenzoate of one-step synthesis method

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20170510

RJ01 Rejection of invention patent application after publication